Anika Therapeutics (ANIK) EPS (2010 - 2026)
Anika Therapeutics (ANIK) EPS from Jun 30, 2010 to Mar 31, 2026. The TTM Anika Therapeutics (ANIK) EPS is -$0.79. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Anika Therapeutics (ANIK) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -79.61% |
| 3 Years TTM | -19.40% |
| 5 Years TTM | -15.90% |
Annual EPS change of Anika Therapeutics (ANIK)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.38 | -51.64% |
| 2025 | -$0.78 | -79.97% |
| 2024 | -$3.91 | -30.65% |
| 2023 | -$5.64 | +455.00% |
| 2022 | -$1.02 | -455.28% |
| 2021 | $0.29 | -117.09% |
| 2020 | -$1.67 | -188.06% |
| 2019 | $1.90 | +255.49% |
| 2018 | $0.53 | +13.49% |
| 2017 | $0.47 | -78.83% |
| 2016 | $2.23 | +8.79% |
| 2015 | $2.05 | -20.72% |
| 2014 | $2.58 | +79.15% |
| 2013 | $1.44 | +69.82% |
| 2012 | $0.85 | +36.49% |
| 2011 | $0.62 | +93.93% |
| 2010 | $0.32 | -1.12% |
| 2009 | $0.32 | N/A |
Comparison Anika Therapeutics (ANIK) five years EPS CAGR with competitors
Anika Therapeutics (ANIK) five years EPS CAGR is -15.91%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 101.37% | -737.27% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.58% | -279.68% |
| RGC | Regencell Bioscience Holdings Ltd | 27.66% | -273.88% |
| UTHR | United Therapeutics Corp | 26.56% | -266.97% |
| LFCR | Lifecore Biomedical Inc | 16.09% | -201.16% |
| PAHC | Phibro Animal Health Corp - Class A | 15.27% | -196.01% |
| ZTS | Zoetis Inc - Class A | 10.56% | -166.38% |
| NBIX | Neurocrine Biosciences Inc | 9.25% | -158.17% |
| PBH | Prestige Consumer Healthcare Inc | 8.18% | -151.43% |
| BCRX | Biocryst Pharmaceuticals Inc | 6.24% | -139.23% |
| BHC | Bausch Health Companies Inc | 2.51% | -115.79% |
| RDY | Dr. Reddy`s Laboratories Ltd | 2.45% | -115.39% |
| YCBD | cbdMD Inc | 1.50% | -109.43% |